Centene Corp tiene un precio objetivo de consenso de $49.52 basado en las calificaciones de 22 analistas. El máximo es $89, emitido por TD Cowen el julio 31, 2024. El mínimo es $28, emitido por Baird el julio 25, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Wells Fargo, JP Morgan y Barclays el noviembre 12, 2025, noviembre 4, 2025 y noviembre 4, 2025, respectivamente. Con un precio objetivo promedio de $39 entre Wells Fargo, JP Morgan y Barclays, hay una 7.73% upside implícita para Centene Corp según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/12/2025 | -3.32% | Wells Fargo | $41 → $35 | Maintains | Equal-Weight | |||
11/04/2025 | 4.97% | JP Morgan | $30 → $38 | Maintains | Neutral | |||
11/04/2025 | 21.55% | Barclays | $35 → $44 | Maintains | Equal-Weight | |||
10/31/2025 | -6.08% | TD Cowen | $30 → $34 | Maintains | Hold | |||
10/31/2025 | 4.97% | Goldman Sachs | $33 → $38 | Maintains | Sell | |||
10/30/2025 | 16.02% | UBS | $31 → $42 | Maintains | Neutral | |||
10/30/2025 | 13.26% | Cantor Fitzgerald | $38 → $41 | Maintains | Neutral | |||
10/30/2025 | 24.31% | Truist Securities | $42 → $45 | Reiterates | Buy → Buy | |||
10/14/2025 | 4.97% | Morgan Stanley | $28 → $38 | Maintains | Equal-Weight | |||
10/14/2025 | -8.84% | Goldman Sachs | → $33 | Initiates | → Sell | |||
10/09/2025 | 10.5% | Mizuho | $28 → $40 | Maintains | Neutral | |||
10/07/2025 | 13.26% | Wells Fargo | $30 → $41 | Maintains | Equal-Weight | |||
09/12/2025 | 7.73% | Truist Securities | $35 → $39 | Maintains | Buy | |||
09/12/2025 | -3.32% | Barclays | $33 → $35 | Maintains | Equal-Weight | |||
09/05/2025 | -0.55% | Bernstein | $40 → $36 | Maintains | Outperform | |||
09/04/2025 | -8.84% | Barclays | $45 → $33 | Maintains | Equal-Weight | |||
08/26/2025 | 4.97% | Cantor Fitzgerald | $38 → $38 | Reiterates | Neutral → Neutral | |||
08/04/2025 | -22.65% | Morgan Stanley | $33 → $28 | Maintains | Equal-Weight | |||
07/29/2025 | -17.13% | JP Morgan | $48 → $30 | Maintains | Neutral | |||
07/28/2025 | -14.37% | UBS | $45 → $31 | Maintains | Neutral | |||
07/28/2025 | -3.32% | Truist Securities | $42 → $35 | Maintains | Buy | |||
07/28/2025 | 18.78% | Oppenheimer | $51 → $43 | Maintains | Outperform | |||
07/28/2025 | 4.97% | Cantor Fitzgerald | $65 → $38 | Downgrade | Overweight → Neutral | |||
07/25/2025 | -22.65% | Baird | $68 → $28 | Maintains | Neutral | |||
07/23/2025 | -17.13% | Wells Fargo | $72 → $30 | Downgrade | Overweight → Equal-Weight | |||
07/21/2025 | -8.84% | TD Cowen | $73 → $33 | Downgrade | Buy → Hold | |||
07/16/2025 | 16.02% | Truist Securities | $84 → $42 | Maintains | Buy | |||
07/16/2025 | -17.13% | B of A Securities | $52 → $30 | Downgrade | Neutral → Underperform | |||
07/15/2025 | 40.88% | Oppenheimer | $85 → $51 | Maintains | Outperform | |||
07/11/2025 | 10.5% | Mizuho | $71 → $40 | Maintains | Neutral | |||
07/10/2025 | -8.84% | Morgan Stanley | $70 → $33 | Downgrade | Overweight → Equal-Weight | |||
07/02/2025 | 24.31% | Barclays | $65 → $45 | Maintains | Equal-Weight | |||
07/02/2025 | 43.64% | B of A Securities | $65 → $52 | Maintains | Neutral | |||
07/02/2025 | 79.56% | Cantor Fitzgerald | $90 → $65 | Maintains | Overweight | |||
07/02/2025 | 24.31% | UBS | $80 → $45 | Downgrade | Buy → Neutral | |||
07/02/2025 | 32.59% | JP Morgan | $75 → $48 | Downgrade | Overweight → Neutral | |||
06/09/2025 | 93.37% | Morgan Stanley | → $70 | Initiates | → Overweight | |||
06/02/2025 | 79.56% | Barclays | $84 → $65 | Downgrade | Overweight → Equal-Weight | |||
04/29/2025 | 68.51% | Jefferies | $64 → $61 | Maintains | Hold | |||
04/29/2025 | — | Guggenheim | — | Reiterates | Neutral → Neutral | |||
04/28/2025 | 132.04% | Barclays | $93 → $84 | Maintains | Overweight | |||
04/15/2025 | 90.61% | Baird | $71 → $69 | Maintains | Neutral | |||
04/09/2025 | — | Guggenheim | — | Initiates | → Neutral | |||
04/08/2025 | 76.79% | Jefferies | $53 → $64 | Upgrade | Underperform → Hold | |||
02/14/2025 | 98.89% | Wells Fargo | $76 → $72 | Maintains | Overweight | |||
12/17/2024 | 107.18% | JP Morgan | $80 → $75 | Assumes | Neutral → Overweight | |||
12/13/2024 | 101.65% | Stephens & Co. | $75 → $73 | Maintains | Equal-Weight | |||
12/13/2024 | 132.04% | Truist Securities | $89 → $84 | Maintains | Buy | |||
12/13/2024 | 156.9% | Barclays | $91 → $93 | Maintains | Overweight | |||
12/13/2024 | 134.8% | Oppenheimer | $95 → $85 | Maintains | Outperform | |||
12/13/2024 | 120.99% | UBS | $79 → $80 | Upgrade | Neutral → Buy | |||
12/11/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
12/10/2024 | 43.64% | Jefferies | $68 → $52 | Downgrade | Hold → Underperform | |||
11/04/2024 | 148.62% | Wells Fargo | $91 → $90 | Maintains | Overweight | |||
10/30/2024 | 143.09% | Bernstein | $96 → $88 | Maintains | Outperform | |||
10/29/2024 | 151.38% | Barclays | $97 → $91 | Maintains | Overweight | |||
10/25/2024 | 82.32% | Baird | $83 → $66 | Maintains | Neutral | |||
10/01/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
09/20/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
09/13/2024 | 151.38% | Wells Fargo | $93 → $91 | Maintains | Overweight | |||
09/10/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
09/05/2024 | 167.95% | Barclays | $98 → $97 | Maintains | Overweight | |||
08/22/2024 | 170.71% | Barclays | $90 → $98 | Maintains | Overweight | |||
08/19/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
08/05/2024 | 115.47% | Stephens & Co. | $78 → $78 | Reiterates | Equal-Weight → Equal-Weight | |||
08/05/2024 | 156.9% | Wells Fargo | $81 → $93 | Maintains | Overweight | |||
08/02/2024 | 140.33% | Deutsche Bank | $82 → $87 | Maintains | Hold | |||
07/31/2024 | 145.85% | TD Cowen | $80 → $89 | Maintains | Buy | |||
07/29/2024 | 162.43% | Oppenheimer | $110 → $95 | Maintains | Outperform | |||
07/24/2024 | 120.99% | TD Cowen | $91 → $80 | Maintains | Buy | |||
07/24/2024 | 90.61% | Jefferies | $83 → $69 | Downgrade | Buy → Hold | |||
07/23/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
07/22/2024 | 123.75% | Wells Fargo | $93 → $81 | Maintains | Overweight | |||
07/15/2024 | 145.85% | Truist Securities | $92 → $89 | Maintains | Buy | |||
07/11/2024 | 129.28% | Jefferies | $90 → $83 | Maintains | Buy | |||
07/10/2024 | 120.99% | JP Morgan | $85 → $80 | Maintains | Neutral | |||
06/21/2024 | 203.86% | Oppenheimer | $110 → $110 | Reiterates | Outperform → Outperform | |||
06/12/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
05/30/2024 | 129.28% | Stephens & Co. | $83 → $83 | Reiterates | Equal-Weight → Equal-Weight | |||
05/30/2024 | 129.28% | Baird | → $83 | Initiates | → Neutral | |||
05/02/2024 | 187.29% | Barclays | $101 → $104 | Maintains | Overweight | |||
04/30/2024 | 126.52% | Deutsche Bank | $81 → $82 | Maintains | Hold | |||
04/29/2024 | 203.86% | Oppenheimer | $110 → $110 | Maintains | Outperform | |||
04/15/2024 | 156.9% | Wells Fargo | $89 → $93 | Maintains | Overweight | |||
04/08/2024 | 145.85% | Wells Fargo | $94 → $89 | Maintains | Overweight | |||
04/04/2024 | 148.62% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
03/25/2024 | 134.8% | Stephens & Co. | $92 → $85 | Downgrade | Overweight → Equal-Weight | |||
03/21/2024 | 134.8% | Stephens & Co. | $92 → $85 | Downgrade | Overweight → Equal-Weight | |||
03/20/2024 | 159.66% | Wells Fargo | $90 → $94 | Maintains | Overweight | |||
03/06/2024 | 179% | Barclays | → $101 | Initiates | → Overweight | |||
01/02/2024 | 148.62% | Wells Fargo | $82 → $90 | Upgrade | Equal-Weight → Overweight | |||
12/21/2023 | 137.57% | Truist Securities | $83 → $86 | Maintains | Buy | |||
12/21/2023 | 118.23% | UBS | $72 → $79 | Maintains | Neutral | |||
12/15/2023 | 148.62% | Cantor Fitzgerald | $82 → $90 | Maintains | Overweight | |||
12/13/2023 | 126.52% | Wells Fargo | $74 → $82 | Maintains | Equal-Weight | |||
11/21/2023 | 126.52% | Cantor Fitzgerald | → $82 | Reiterates | Overweight → Overweight | |||
10/26/2023 | 104.42% | Wells Fargo | $71 → $74 | Maintains | Equal-Weight | |||
10/09/2023 | 123.75% | Jefferies | $82 → $81 | Maintains | Buy | |||
09/14/2023 | 126.52% | Cantor Fitzgerald | → $82 | Reiterates | Overweight → Overweight | |||
09/05/2023 | 98.89% | B of A Securities | $79 → $72 | Upgrade | Underperform → Neutral |
El último precio objetivo de Centene (NYSE:CNC) fue comunicado por Wells Fargo el noviembre 12, 2025. La firma de analistas fijó un precio objetivo para $35.00 que espera CNC a fall dentro de 12 meses (un posible -3.32% downside). 53 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Centene (NYSE:CNC) fue proporcionada por Wells Fargo, y Centene mantuvo su equal-weight calificación.
La última revisión al alza de Centene Corp se produjo en abril 8, 2025, cuando Jefferies elevó su precio objetivo a $64. Jefferies anteriormente tenía an underperform para Centene Corp.
La última revisión a la baja de Centene Corp se produjo en julio 28, 2025, cuando Cantor Fitzgerald cambió su precio objetivo de $65 a $38 para Centene Corp.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Centene, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Centene se registró el noviembre 12, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 12, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Centene (CNC) fue un mantuvo con un precio objetivo de $41.00 a $35.00. El precio actual al que cotiza Centene (CNC) es de $36.20, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.